Product development services toward an NDA for a new compound will be provided by PharmaKinetics for "a leading U.S. pharmaceutical manufacturer," the firm said. Under the agreement, PharmaKinetics will receive $10 mil. plus a royalty on any product sales.
You may also be interested in...
Trial diversity is among the issues that stakeholders worry could hinder vaccine uptake.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
A study with nearly 500 patients with vitamin D levels tested within a year before receiving COVID-19 tests found subjects deficient in the nutrient had 1.77 greater chance of testing positive. Researchers say RCTs are needed to determine if broad population interventions are necessary.